Empagliflozin/Metformin Tablet 12.5/500 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
MFDS item code 202302634 · Approved 2023.09.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication aids in blood sugar control for adult patients with type 2 diabetes through a combination therapy of empagliflozin and metformin, alongside dietary management and exercise therapy. It is particularly effective for those whose blood sugar is not adequately controlled, and patients with cardiovascular diseases should refer to specialist advice. This medication improves the blood sugar levels of diabetic patients, aiding in health management.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients: In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is an antidiabetic agent that helps manage blood sugar levels. During usage, there may be a risk of severe lactic acidosis, a dangerous condition, so patients should be vigilant for symptoms. Caution is needed particularly when used with insulin or sulfonylureas as hypoglycemia may occur. Patients with severely impaired kidney function or acute kidney impairment should not take this medication. Moreover, this medication should not be used by patients with type 1 diabetes or a history of lactic acidosis or diabetic ketoacidosis. Patients scheduled for surgery or those receiving radiocontrast containing iodine should temporarily discontinue this medication for a certain period, resuming it only after kidney function recovery. Pregnant or breastfeeding women are also advised against taking this medication. Regular monitoring of kidney function is necessary during treatment to confirm no abnormalities, and particular caution is needed for the elderly or those with weakened kidney function. This medication may cause side effects such as hypoglycemia, urinary tract infections, genital infections, and increased urination, so if symptoms occur, immediate consultation with healthcare professionals is necessary. Furthermore, if signs of fluid loss or dehydration occur, the medication may be temporarily discontinued. Vitamin B12 levels may decrease, so regular blood tests are recommended if necessary. Alcohol may increase the risk of side effects from this medication, so it is best to avoid drinking during treatment. This medication may interact with other drugs, so if taking any other medications, always inform your doctor or pharmacist. Elderly patients should have dose adjustments and regular monitoring due to the risk of side effects from decreased kidney function. In case of overdose, seek immediate medical care, as some components can be removed by hemodialysis. This medication is not recommended for children, and it should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air and moisture. It is important to maintain a storage temperature between 1°C and 30°C. This way, the components of the medication remain unchanged and can be used safely.
Oval film-coated tablet that is convex on both sides, purplish with light brown tint
10 tablets/box [10 tablets/PTPX1], 60 tablets/box [10 tablets/PTPX6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.